Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis?

Statistics

¿Es el cinacalcet un tratamiento coste-efectivo en el hiperparatiroidismo secundario severo en pacientes en hemodiálisis?

María Dolores Arenasa, Pablo Rebollob, Fernando Alvarez-Udec, Luis Prietod, Maria Teresa Gila, Tamara Maleka, Analía Moledousa, Carlos Núñeza

a Hospital Perpetuo Socorro, Alicante, Alicante, España,

b BAP Health Outcomes, Oviedo, Asturias, España,

c Hospital General de Segovia Segovia Segovia España,

d Health Outcomes Research Consultant, Madrid, Madrid, España,

Read

9584

Times
was read the article

3457

Total PDF

6127

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	54	82	136
2025 5	83	52	135
2025 4	56	26	82
2025 3	125	70	195
2025 2	80	34	114
2025 1	88	47	135
2024 12	74	32	106
2024 11	63	50	113
2024 10	67	54	121
2024 9	79	61	140
2024 8	74	121	195
2024 7	70	45	115
2024 6	65	62	127
2024 5	63	56	119
2024 4	49	42	91
2024 3	33	42	75
2024 2	34	52	86
2024 1	32	36	68
2023 12	20	25	45
2023 11	41	39	80
2023 10	37	48	85
2023 9	36	26	62
2023 8	43	70	113
2023 7	26	52	78
2023 6	40	30	70
2023 5	56	52	108
2023 4	34	42	76
2023 3	52	31	83
2023 2	25	15	40
2023 1	34	26	60
2022 12	39	47	86
2022 11	34	50	84
2022 10	37	49	86
2022 9	33	35	68
2022 8	31	55	86
2022 7	35	46	81
2022 6	27	29	56
2022 5	32	35	67
2022 4	32	43	75
2022 3	41	51	92
2022 2	36	55	91
2022 1	36	37	73
2021 12	35	39	74
2021 11	42	49	91
2021 10	40	58	98
2021 9	28	52	80
2021 8	38	45	83
2021 7	37	39	76
2021 6	22	37	59
2021 5	35	43	78
2021 4	71	53	124
2021 3	48	25	73
2021 2	54	21	75
2021 1	30	14	44
2020 12	22	12	34
2020 11	29	17	46
2020 10	20	15	35
2020 9	21	18	39
2020 8	36	13	49
2020 7	39	9	48
2020 6	46	11	57
2020 5	45	9	54
2020 4	35	19	54
2020 3	42	5	47
2020 2	44	12	56
2020 1	63	21	84
2019 12	59	29	88
2019 11	56	28	84
2019 10	38	12	50
2019 9	34	23	57
2019 8	25	18	43
2019 7	38	23	61
2019 6	39	5	44
2019 5	28	20	48
2019 4	57	39	96
2019 3	25	20	45
2019 2	31	12	43
2019 1	22	16	38
2018 12	59	30	89
2018 11	68	27	95
2018 10	52	21	73
2018 9	40	30	70
2018 8	40	35	75
2018 7	38	26	64
2018 6	35	20	55
2018 5	33	14	47
2018 4	39	14	53
2018 3	40	12	52
2018 2	62	7	69
2018 1	34	10	44
2017 12	66	12	78
2017 11	33	13	46
2017 10	27	11	38
2017 9	29	23	52
2017 8	31	41	72
2017 7	36	33	69
2017 6	35	32	67
2017 5	41	39	80
2017 4	30	41	71
2017 3	13	33	46
2017 2	18	15	33
2017 1	36	23	59
2016 12	51	9	60
2016 11	48	11	59
2016 10	72	14	86
2016 9	113	7	120
2016 8	176	8	184
2016 7	127	13	140
2016 6	99	0	99
2016 5	116	0	116
2016 4	101	0	101
2016 3	113	0	113
2016 2	87	0	87
2016 1	91	0	91
2015 12	93	0	93
2015 11	90	0	90
2015 10	66	0	66
2015 9	81	0	81
2015 8	76	0	76
2015 7	63	0	63
2015 6	45	0	45
2015 5	58	0	58
2015 4	6	0	6

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter